Beta Adrenoceptor Agonists Market: Inhaled Bronchodilators and Selective Beta-2 Therapeutics Driving Growth
Surging global prevalence of asthma and chronic obstructive pulmonary disease (COPD), expanding clinical adoption of selective beta-2 adrenoceptor agonists, and continuous formulation advances in dry-powder inhalers (DPIs) are driving robust expansion across the global Beta Adrenoceptor Agonists Market. Beta adrenoceptor agonists act by binding to G-protein coupled beta-adrenergic receptors,...
0 Σχόλια 0 Μοιράστηκε 23 Views 0 Προεπισκόπηση